# Zylox-Tonbridge and GL Capital to acquire 16.73% stake in LifeTech Scientific for $189M

Zylox-Tonbridge Medical Technology and GL Capital conditionally agreed to subscribe for approximately 16.73% of LifeTech Scientific Corporation for HK$1.482 billion ($189 million), with intent to pursue a full merger to create China's largest listed cardiovascular interventional device company.

- Type: Acquisition
- Announced: 2026-11-06
- Where: China
- Value: $189.0M
- Status: announced
- Products: cardiovascular interventional devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LifeTech Scientific](https://endata.com/companies/38475.md) (target)
- [Zylox-Tonbridge Medical Technology](https://endata.com/companies/94974.md) (acquirer)
- [GL Capital](https://endata.com/companies/94975.md) (acquirer)

## Sources

- [techtimes.com](https://www.techtimes.com/articles/330232/20261107/chinas-medtech-merger-wave-zylox-tonbridge-puts-189m-lifetech-scientific-build-cardiovascular.htm), 2026-11-07: "both buyers have made explicit in the transaction announcement their intent to pursue a full merger — a step that would create China's most broadly diversified listed cardiovascular interventional device company."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.